🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Tesla, Mirati Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Published 09/10/2023, 10:57
Updated 09/10/2023, 12:10
© Reuters.  Tesla, Mirati Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
TSLA
-
CAMT
-
MRTX
-
INMD
-
MBLY3
-
GLBE
-

Benzinga - by Lisa Levin, Benzinga Editor.

U.S. stock futures traded lower this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session.

  • TPG RE Finance Trust, Inc. (NYSE: TRTX) shares tumbled 8.1% to $5.64 in pre-market trading.
  • InMode Ltd. (NASDAQ: INMD) shares declined 7% to $26.70 in pre-market trading.
  • Gilat Satellite Networks Ltd. (NASDAQ: GILT) shares fell 5.7% to $6.01 in pre-market.
  • Mobileye Global Inc. (NASDAQ: MBLY) shares declined 5.6% to $39.14 in pre-market trading after gaining over 2% on Friday.
  • Camtek Ltd. (NASDAQ: CAMT) shares declined 5.1% to $60.13 in pre-market trading after gaining over 3% on Friday.
  • Global-e Online Ltd. (NASDAQ: GLBE) shares fell 4.1% to $38.39 in pre-market trading, after gaining over 3% on Friday.
  • Spotify Technology S.A. (NYSE: SPOT) fell 2.2% to $156.95 in pre-market trading. Redburn Atlantic downgraded Spotify from Buy to Neutral and lowered the price target from $170 to $160.
  • Mirati Therapeutics, Inc. (NASDAQ: MRTX) shares slipped 2% to $59.00 in pre-market trading after Bristol Myers Squibb (NYSE: BMY) announced plans to acquire the company in a deal worth up to $5.8 billion. Jefferies downgraded Mirati Therapeutics to Hold following the announcement.
  • Tesla, Inc. (NASDAQ: TSLA) shares fell 1.6% to $256.44 in pre-market trading. Reuters reported that Tesla sold 74,073 China-made electric vehicles in September, down 10.9% year-over-year, according to data from the China Passenger Car Association.
Now Read This: Top 4 Health Care Stocks That Are Preparing To Pump This Quarter

Don’t forget to check out our premarket coverage here

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.